188 related articles for article (PubMed ID: 22377759)
1. Molecular markers of early-stage mycosis fungoides.
Zhang Y; Wang Y; Yu R; Huang Y; Su M; Xiao C; Martinka M; Dutz JP; Zhang X; Zheng Z; Zhou Y
J Invest Dermatol; 2012 Jun; 132(6):1698-706. PubMed ID: 22377759
[TBL] [Abstract][Full Text] [Related]
2. TOX expression in different subtypes of cutaneous lymphoma.
Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
Nguyen GH; Olson LC; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
[TBL] [Abstract][Full Text] [Related]
5. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
Mehdi SJ; Moerman-Herzog A; Wong HK
BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
[TBL] [Abstract][Full Text] [Related]
6. TOX acts an oncological role in mycosis fungoides.
Yu X; Luo Y; Liu J; Liu Y; Sun Q
PLoS One; 2015; 10(3):e0117479. PubMed ID: 25811617
[TBL] [Abstract][Full Text] [Related]
7. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.
Dalton SR; Chandler WM; Abuzeid M; Hossler EW; Ferringer T; Elston DM; LeBoit PE
Am J Dermatopathol; 2012 Aug; 34(6):586-91. PubMed ID: 22814317
[TBL] [Abstract][Full Text] [Related]
8. TOX, TWIST1, STAT4, and SATB1 protein expressions in early-stage mycosis fungoides.
Örnek S; Ozekinci S; Ipin T; Kocaturk E
J Cutan Pathol; 2024 Mar; 51(3):232-238. PubMed ID: 37932931
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
11. Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients.
Marschalkó M; Erős N; Kontár O; Hidvégi B; Telek J; Hársing J; Jókai H; Bottlik G; Rajnai H; Szepesi Á; Matolcsy A; Kárpáti S; Csomor J
J Eur Acad Dermatol Venereol; 2015 May; 29(5):964-72. PubMed ID: 25406034
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
13. αEβ7 Expression Increases With the Extent of Cutaneous Involvement in Mycosis Fungoides.
Barata MC; Teixeira SP; Batista MD; Tomimori J; Landman G; Silva MRR
Am J Dermatopathol; 2019 Sep; 41(9):630-636. PubMed ID: 30839339
[TBL] [Abstract][Full Text] [Related]
14. Expression of T-bet and GATA-3 in early mycosis fungoides and spongiotic dermatitis.
Elbendary A; Parikh K; Elattar I; Truong J; Elston DM
J Am Acad Dermatol; 2016 May; 74(5):1012-4. PubMed ID: 27085233
[No Abstract] [Full Text] [Related]
15. Regarding the algorithm for the diagnosis of early mycosis fungoides proposed by the International Society for Cutaneous Lymphomas: suggestions from routine histopathology practice.
Ferrara G; Di Blasi A; Zalaudek I; Argenziano G; Cerroni L
J Cutan Pathol; 2008 Jun; 35(6):549-53. PubMed ID: 18201238
[TBL] [Abstract][Full Text] [Related]
16. Mycosis fungoides with spontaneously regressing CD30-positive tumorous lesions.
Woodrow SL; Basarab T; Russell Jones R
Clin Exp Dermatol; 1996 Sep; 21(5):370-3. PubMed ID: 9136160
[TBL] [Abstract][Full Text] [Related]
17. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
[TBL] [Abstract][Full Text] [Related]
18. [Mycosis fungoides or inflammatory dermatitis: differential diagnosis between early lymphoma and inflammation in skin biopsies].
Oschlies I; Klapper W
Pathologe; 2013 May; 34(3):215-24. PubMed ID: 23549914
[TBL] [Abstract][Full Text] [Related]
19. Mycosis fungoides with spongiosis: A potential diagnostic pitfall.
Shamim H; Johnson EF; Gibson LE; Comfere N
J Cutan Pathol; 2019 Sep; 46(9):645-652. PubMed ID: 30989664
[TBL] [Abstract][Full Text] [Related]
20. Genetic markers associated with progression in early mycosis fungoides.
Johnson VE; Vonderheid EC; Hess AD; Eischen CM; McGirt LY
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1431-5. PubMed ID: 24171863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
